RxDoctor Payments Data

Daniel Badenhop, MD

Family Medicine · Marysville, OHNPI 1376594168

Payments from drug & device makers

$6,131in general payments, 2019–2025

Across 463 payments — averaging $13.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$874
  • Lilly USA, LLC$657
  • Novo Nordisk$639
  • Pfizer$543
  • GSK$380
  • AstraZeneca$349
  • plus $3K from 34 others

What the payments were for

  • Food & beverage$6,04199%
  • Education$901%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,131 in reported general payments places this provider in the 85th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$50,713
Medicare patients
253
Services billed
1,043

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban109$106,662
FarxigaDapagliflozin Propanediol97$86,769
Trelegy ElliptaFluticasone/Umeclidin/Vilanter88$73,308
JardianceEmpagliflozin67$69,750
OzempicSemaglutide45$63,251
MounjaroTirzepatide44$61,026
TrulicityDulaglutide20$46,528
JanuviaSitagliptin Phosphate37$35,872
RybelsusSemaglutide23$34,009
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog24$22,995
Tresiba Flextouch U-200Insulin Degludec23$21,587
XareltoRivaroxaban13$21,468
LinzessLinaclotide22$15,974
MyrbetriqMirabegron35$15,334
TradjentaLinagliptin16$15,021

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$657$107,55464 claims
PfizerEliquis$543$106,662109 claims
AstraZenecaFarxiga, Breztri Aerosphere$349$99,473118 claims
Novo NordiskOzempic, Rybelsus$639$97,26068 claims
Boehringer IngelheimJardiance, Tradjenta$202$84,77183 claims
GSKTrelegy Ellipta$380$73,30888 claims
MerckJanuvia, Janumet$216$46,47049 claims
Johnson & JohnsonXarelto$142$21,46813 claims
AbbVieLinzess$874$15,97422 claims
Astellas Pharma US IncMyrbetriq$135$15,33435 claims
Sanofi-aventis U.S. LLCLantus$139$1,98913 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$16$1,914233 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Marysville

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →